Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4IB80
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006396 | RNA processing | 6 | 11 |
GO:0006399 | tRNA metabolic process | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008033 | tRNA processing | 8 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0034470 | ncRNA processing | 7 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034660 | ncRNA metabolic process | 6 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016432 | tRNA-uridine aminocarboxypropyltransferase activity | 4 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 3 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 11 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 228 | 232 | PF00656 | 0.706 |
CLV_C14_Caspase3-7 | 252 | 256 | PF00656 | 0.486 |
CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.562 |
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 50 | 52 | PF00675 | 0.323 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.558 |
CLV_PCSK_KEX2_1 | 217 | 219 | PF00082 | 0.567 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.418 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.331 |
CLV_PCSK_PC1ET2_1 | 2 | 4 | PF00082 | 0.549 |
CLV_PCSK_PC1ET2_1 | 49 | 51 | PF00082 | 0.347 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.484 |
CLV_Separin_Metazoa | 324 | 328 | PF03568 | 0.563 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.583 |
DEG_SPOP_SBC_1 | 250 | 254 | PF00917 | 0.406 |
DOC_CYCLIN_RxL_1 | 18 | 29 | PF00134 | 0.390 |
DOC_CYCLIN_RxL_1 | 46 | 57 | PF00134 | 0.320 |
DOC_CYCLIN_yCln2_LP_2 | 71 | 77 | PF00134 | 0.257 |
DOC_MAPK_gen_1 | 161 | 170 | PF00069 | 0.306 |
DOC_PP1_RVXF_1 | 139 | 146 | PF00149 | 0.238 |
DOC_PP1_RVXF_1 | 22 | 29 | PF00149 | 0.368 |
DOC_PP2B_LxvP_1 | 219 | 222 | PF13499 | 0.506 |
DOC_PP2B_LxvP_1 | 308 | 311 | PF13499 | 0.451 |
DOC_PP2B_LxvP_1 | 71 | 74 | PF13499 | 0.257 |
DOC_PP4_FxxP_1 | 28 | 31 | PF00568 | 0.300 |
DOC_USP7_MATH_1 | 212 | 216 | PF00917 | 0.528 |
DOC_USP7_MATH_1 | 234 | 238 | PF00917 | 0.744 |
DOC_USP7_MATH_1 | 313 | 317 | PF00917 | 0.551 |
DOC_WW_Pin1_4 | 217 | 222 | PF00397 | 0.596 |
DOC_WW_Pin1_4 | 240 | 245 | PF00397 | 0.694 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.238 |
LIG_14-3-3_CanoR_1 | 169 | 178 | PF00244 | 0.296 |
LIG_14-3-3_CanoR_1 | 281 | 287 | PF00244 | 0.450 |
LIG_APCC_ABBA_1 | 60 | 65 | PF00400 | 0.251 |
LIG_APCC_ABBAyCdc20_2 | 141 | 147 | PF00400 | 0.238 |
LIG_BRCT_BRCA1_1 | 24 | 28 | PF00533 | 0.289 |
LIG_eIF4E_1 | 54 | 60 | PF01652 | 0.251 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.238 |
LIG_FHA_2 | 244 | 250 | PF00498 | 0.502 |
LIG_FHA_2 | 301 | 307 | PF00498 | 0.448 |
LIG_LIR_Apic_2 | 25 | 31 | PF02991 | 0.282 |
LIG_LIR_Gen_1 | 303 | 313 | PF02991 | 0.392 |
LIG_LIR_Nem_3 | 106 | 110 | PF02991 | 0.238 |
LIG_LIR_Nem_3 | 138 | 143 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 163 | 168 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 174 | 180 | PF02991 | 0.210 |
LIG_LIR_Nem_3 | 192 | 198 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 266 | 272 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 292 | 298 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 303 | 308 | PF02991 | 0.349 |
LIG_LYPXL_yS_3 | 107 | 110 | PF13949 | 0.238 |
LIG_SH2_CRK | 56 | 60 | PF00017 | 0.238 |
LIG_SH2_GRB2like | 271 | 274 | PF00017 | 0.283 |
LIG_SH2_PTP2 | 275 | 278 | PF00017 | 0.288 |
LIG_SH2_PTP2 | 78 | 81 | PF00017 | 0.257 |
LIG_SH2_STAP1 | 56 | 60 | PF00017 | 0.251 |
LIG_SH2_STAT3 | 201 | 204 | PF00017 | 0.293 |
LIG_SH2_STAT3 | 271 | 274 | PF00017 | 0.283 |
LIG_SH2_STAT3 | 298 | 301 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.238 |
LIG_SH2_STAT5 | 196 | 199 | PF00017 | 0.238 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.238 |
LIG_SH2_STAT5 | 271 | 274 | PF00017 | 0.283 |
LIG_SH2_STAT5 | 275 | 278 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 282 | 285 | PF00017 | 0.403 |
LIG_SH2_STAT5 | 290 | 293 | PF00017 | 0.405 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.241 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.257 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.474 |
LIG_SH3_3 | 102 | 108 | PF00018 | 0.245 |
LIG_SH3_3 | 118 | 124 | PF00018 | 0.218 |
LIG_SH3_3 | 306 | 312 | PF00018 | 0.417 |
LIG_SH3_3 | 319 | 325 | PF00018 | 0.558 |
LIG_SH3_3 | 77 | 83 | PF00018 | 0.437 |
LIG_SUMO_SIM_anti_2 | 117 | 122 | PF11976 | 0.259 |
LIG_TYR_ITIM | 105 | 110 | PF00017 | 0.212 |
LIG_WW_3 | 324 | 328 | PF00397 | 0.563 |
MOD_CDK_SPK_2 | 240 | 245 | PF00069 | 0.558 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.281 |
MOD_CK1_1 | 229 | 235 | PF00069 | 0.736 |
MOD_CK1_1 | 237 | 243 | PF00069 | 0.680 |
MOD_CK1_1 | 316 | 322 | PF00069 | 0.670 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.237 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.505 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.541 |
MOD_Cter_Amidation | 215 | 218 | PF01082 | 0.455 |
MOD_GlcNHglycan | 213 | 217 | PF01048 | 0.579 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.723 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.567 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.493 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.254 |
MOD_GSK3_1 | 183 | 190 | PF00069 | 0.278 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.299 |
MOD_GSK3_1 | 229 | 236 | PF00069 | 0.765 |
MOD_GSK3_1 | 250 | 257 | PF00069 | 0.513 |
MOD_GSK3_1 | 316 | 323 | PF00069 | 0.643 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.243 |
MOD_LATS_1 | 167 | 173 | PF00433 | 0.316 |
MOD_N-GLC_1 | 301 | 306 | PF02516 | 0.417 |
MOD_N-GLC_1 | 316 | 321 | PF02516 | 0.630 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.279 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.338 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.238 |
MOD_NEK2_2 | 58 | 63 | PF00069 | 0.259 |
MOD_PIKK_1 | 169 | 175 | PF00454 | 0.281 |
MOD_PIKK_1 | 200 | 206 | PF00454 | 0.293 |
MOD_PKA_2 | 160 | 166 | PF00069 | 0.293 |
MOD_PKA_2 | 280 | 286 | PF00069 | 0.453 |
MOD_Plk_1 | 116 | 122 | PF00069 | 0.312 |
MOD_Plk_1 | 125 | 131 | PF00069 | 0.355 |
MOD_Plk_1 | 146 | 152 | PF00069 | 0.257 |
MOD_Plk_1 | 254 | 260 | PF00069 | 0.369 |
MOD_Plk_1 | 301 | 307 | PF00069 | 0.424 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.238 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.247 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.305 |
MOD_ProDKin_1 | 217 | 223 | PF00069 | 0.597 |
MOD_ProDKin_1 | 240 | 246 | PF00069 | 0.690 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.238 |
MOD_SUMO_rev_2 | 128 | 137 | PF00179 | 0.220 |
MOD_SUMO_rev_2 | 228 | 235 | PF00179 | 0.561 |
TRG_DiLeu_BaEn_1 | 263 | 268 | PF01217 | 0.307 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.238 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.371 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.238 |
TRG_ENDOCYTIC_2 | 275 | 278 | PF00928 | 0.293 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.238 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.257 |
TRG_ER_diArg_1 | 217 | 219 | PF00400 | 0.454 |
TRG_ER_diArg_1 | 33 | 36 | PF00400 | 0.369 |
TRG_ER_diArg_1 | 50 | 52 | PF00400 | 0.367 |
TRG_NLS_MonoCore_2 | 1 | 6 | PF00514 | 0.650 |
TRG_NLS_MonoExtN_4 | 46 | 53 | PF00514 | 0.386 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCD7 | Leptomonas seymouri | 76% | 100% |
A0A0S4IR26 | Bodo saltans | 49% | 100% |
A0A1X0P5T8 | Trypanosomatidae | 64% | 100% |
A0A3S7X980 | Leishmania donovani | 100% | 100% |
A4HMK1 | Leishmania braziliensis | 85% | 100% |
C9ZZK5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
E9AF01 | Leishmania major | 94% | 100% |
E9B657 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q5RCQ0 | Pongo abelii | 33% | 100% |
Q8N5C7 | Homo sapiens | 33% | 100% |
Q9D8U7 | Mus musculus | 34% | 100% |
V5B8W4 | Trypanosoma cruzi | 62% | 100% |